The vaginal microbiome, a complex ecosystem inhabited by diverse microbial communities, plays a pivotal role in maintaining reproductive health and protecting against infections. Recent advancements in sequencing technologies and metabolomics have revolutionized our understanding of the vaginal microbiota and its metabolites, shedding light on their intricate interactions with host genetics and immune responses. Despite these breakthroughs, the genetic underpinnings of vaginal microbial composition, its evolutionary trajectory, and the clinical implications of vaginal metabolites remain incompletely understood. For instance, specific bacterial species within the vaginal microbiome are known to modulate immune pathways, influencing susceptibility to sexually transmitted infections and reproductive disorders. However, the genetic factors that dictate the colonization and persistence of these beneficial or pathogenic species are largely unexplored. Similarly, the metabolic profiles associated with vaginal health and disease states hold promise for biomarker discovery, but their translational potential into clinical practice remains untapped. This Research Topic aims to address these knowledge gaps by consolidating the latest findings and fostering interdisciplinary discussions.
This Research Topic is focused on advancing the understanding of the vaginal microbiome and its metabolites, with emphasis on genetic determinants, evolutionary dynamics, and clinical applications. It aims to tackle the challenges in translating current research into improved diagnostics, therapeutics, and personalized health strategies for women's reproductive health.
We invite submissions that explore the following themes:
• Genetic influences on vaginal microbiome composition and function, including host genetics and microbial genomics.
• Evolutionary perspectives of the vaginal microbiome, examining its adaptation to host environments and changes across lifespan or populations.
• Metabolite profiling in vaginal health and disease, with emphasis on biomarker discovery and mechanistic insights.
• Clinical implications of vaginal microbiome research, encompassing diagnostic and therapeutic potential, particularly in the context of reproductive disorders and infections.
Contributions should present novel data, reviews, or perspectives that significantly contribute to our understanding of the vaginal microbiome and its metabolites, with a clear emphasis on genetics, evolution, and clinical relevance.
The vaginal microbiome, a complex ecosystem inhabited by diverse microbial communities, plays a pivotal role in maintaining reproductive health and protecting against infections. Recent advancements in sequencing technologies and metabolomics have revolutionized our understanding of the vaginal microbiota and its metabolites, shedding light on their intricate interactions with host genetics and immune responses. Despite these breakthroughs, the genetic underpinnings of vaginal microbial composition, its evolutionary trajectory, and the clinical implications of vaginal metabolites remain incompletely understood. For instance, specific bacterial species within the vaginal microbiome are known to modulate immune pathways, influencing susceptibility to sexually transmitted infections and reproductive disorders. However, the genetic factors that dictate the colonization and persistence of these beneficial or pathogenic species are largely unexplored. Similarly, the metabolic profiles associated with vaginal health and disease states hold promise for biomarker discovery, but their translational potential into clinical practice remains untapped. This Research Topic aims to address these knowledge gaps by consolidating the latest findings and fostering interdisciplinary discussions.
This Research Topic is focused on advancing the understanding of the vaginal microbiome and its metabolites, with emphasis on genetic determinants, evolutionary dynamics, and clinical applications. It aims to tackle the challenges in translating current research into improved diagnostics, therapeutics, and personalized health strategies for women's reproductive health.
We invite submissions that explore the following themes:
• Genetic influences on vaginal microbiome composition and function, including host genetics and microbial genomics.
• Evolutionary perspectives of the vaginal microbiome, examining its adaptation to host environments and changes across lifespan or populations.
• Metabolite profiling in vaginal health and disease, with emphasis on biomarker discovery and mechanistic insights.
• Clinical implications of vaginal microbiome research, encompassing diagnostic and therapeutic potential, particularly in the context of reproductive disorders and infections.
Contributions should present novel data, reviews, or perspectives that significantly contribute to our understanding of the vaginal microbiome and its metabolites, with a clear emphasis on genetics, evolution, and clinical relevance.